Company Filing History:
Years Active: 2014-2020
Title: Ollivier Francis Nicolas Gavard: Innovator in Conjugation Processes
Introduction
Ollivier Francis Nicolas Gavard is a notable inventor based in Rixensart, Belgium. He has made significant contributions to the field of biotechnology, particularly in the area of conjugation processes. With a total of four patents to his name, Gavard's work has implications for vaccine development and other medical applications.
Latest Patents
Gavard's latest patents include a process for conjugation of an antigen, which focuses on improving the efficiency and effectiveness of antigen conjugation. Another significant patent involves the conjugation process of bacterial polysaccharides to carrier proteins, utilizing reductive amination techniques. These innovations are crucial for enhancing the performance of vaccines and therapeutic agents.
Career Highlights
Ollivier Gavard is currently associated with GlaxoSmithKline Biologicals SA, a leading company in the pharmaceutical and biotechnology sector. His role at the company allows him to apply his expertise in developing advanced conjugation methods that can lead to improved health outcomes.
Collaborations
Gavard has collaborated with esteemed colleagues such as Ralph Leon Biemans and Pierre Duvivier. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of ideas in the field of biotechnology.
Conclusion
Ollivier Francis Nicolas Gavard is a prominent figure in the realm of biotechnology, with a focus on conjugation processes that have the potential to revolutionize vaccine development. His contributions and collaborations continue to impact the industry positively.